Welcome to our dedicated page for Kopin SEC filings (Ticker: KOPN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Kopin Corporation’s disclosures can feel like navigating both military contract jargon and semiconductor engineering notes at once. Buried inside a single 10-K are defense backlog metrics, microdisplay yield data, and R&D milestones that shape future headset wins. If you have ever asked, “How do I locate Kopin insider trading Form 4 transactions?� or “Where’s the Kopin quarterly earnings report 10-Q filing?� you know the challenge.
Stock Titan solves this complexity. Our AI instantly tags every Kopin annual report 10-K simplified, highlights segments, and offers real-time alerts for Kopin Form 4 insider transactions real-time. Need fast answers? Try the on-page questions built for Google and AI assistants: “Kopin SEC filings explained simply,� “understanding Kopin SEC documents with AI,� or “Kopin 8-K material events explained.� Each click opens an AI-powered summary that translates accounting footnotes and defense contract clauses into plain English.
Whether you’re monitoring Kopin executive stock transactions Form 4 before a new military order, comparing unit shipments across quarters through our Kopin earnings report filing analysis, or verifying leadership pay with the Kopin proxy statement executive compensation breakdown, you’ll find every document�10-K, 10-Q, 8-K, S-3 and more—updated the moment EDGAR releases it. Key benefits:
- AI summaries that surface revenue by product line in seconds
- AGÕæÈ˹ٷ½-time push alerts for insider buys and sells
- Keyword search inside PDFs for optical component metrics
Stop skimming 200-page PDFs. Our platform turns Kopin’s dense regulatory language into clear insights so you can focus on decisions, not document hunting.
The Free Writing Prospectus outlines the key terms of Morgan Stanley Finance LLC’s Contingent Income Auto-Callable Securities linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index (ticker: SPUMP40). The notes offer a contingent coupon of 9.00%-10.00% per annum, paid monthly if the index closes at or above the 50% coupon-barrier on the relevant observation date. Beginning one year after issuance, the securities are auto-callable quarterly at par if the index is at or above its initial level (100% call threshold). If not redeemed early, investors receive par at maturity on 1 Aug 2030 provided the index has not fallen more than 50%. Should the index close below the 50% downside threshold on the final observation date, principal is reduced 1-for-1, exposing investors to substantial loss (e.g., a 51% decline delivers $490 per $1,000 note).
The issue price is $1,000, but Morgan Stanley’s estimated value is $882.50 (±$32.50), reflecting embedded fees and hedging costs. The notes are unsecured, unsubordinated obligations of Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, and will not be listed on any exchange, limiting secondary-market liquidity. Key risks include credit exposure to Morgan Stanley, potential loss of principal, lack of upside participation beyond coupon payments, early-redemption reinvestment risk, tax uncertainty, and the limited operating history and leveraged methodology of the underlier, which incorporates a 4% annual decrement.
- Issuer: Morgan Stanley Finance LLC (guaranteed by Morgan Stanley)
- Maturity: 5 years (Aug 1 2030) with quarterly call from year 1
- Barriers: 50% coupon & downside threshold; 100% call threshold
- CUSIP: 61778NEA5 | Pricing date: 28 Jul 2025 | Estimated value: $882.50
Kopin Corp director Paul V. Walsh Jr. received a grant of 64,500 restricted stock shares on June 26, 2025. The shares were awarded at $0.00 per share under the company's 2020 Equity Incentive Plan.
Key details of the transaction:
- The restricted stock will fully vest on June 26, 2026
- Following the transaction, Walsh owns a total of 129,000 shares directly
- The shares are subject to restrictions under the company's 2020 Equity Incentive Plan
- The transaction was reported via Form 4 filing, signed by John J. Concannon as attorney-in-fact
This equity grant appears to be part of the company's director compensation program, aligning the director's interests with those of shareholders through stock ownership.
Kopin Corp (KOPN) director Margaret K. Seif received a grant of 64,500 restricted stock shares on June 26, 2025. The shares were awarded at $0.00 per share under the company's 2020 Equity Incentive Plan.
Key details of the transaction:
- The restricted stock will vest on June 26, 2026
- Following the transaction, Seif directly owns 129,000 shares
- The Form 4 was filed through an attorney-in-fact on June 27, 2025
- This was a non-derivative securities transaction with no accompanying options or other derivative securities
This equity grant appears to be part of the company's director compensation program, representing a significant increase in Seif's direct ownership position in the company.
Kopin Corp director Jill Janice Avery received a new grant of restricted stock according to this Form 4 filing. The transaction details include:
- Acquired 64,500 shares of common stock on June 26, 2025
- Shares were granted at $0.00 per share as restricted stock
- Total beneficial ownership following transaction: 159,000 shares (Direct ownership)
- The restricted stock will vest on June 26, 2026
- Grant made under the company's 2020 Equity Incentive Plan
This equity award appears to be part of the company's director compensation program. The shares are subject to a one-year vesting period, indicating a retention mechanism for the director's services. The transaction was reported within the required two-business-day filing window.
Kopin Corp (KOPN) director David J. Nieuwsma received a grant of 64,500 restricted stock shares on June 26, 2025. The shares were awarded at $0.00 per share under the company's 2020 Equity Incentive Plan.
Key details of the transaction:
- The restricted stock will vest on June 26, 2026
- Following the transaction, Nieuwsma now beneficially owns 193,500 shares directly
- The Form 4 was filed by John J. Concannon as attorney-in-fact on June 27, 2025
This equity grant appears to be part of the company's director compensation program, representing a significant increase in Nieuwsma's stake in the company. The one-year vesting period aligns the director's interests with long-term shareholder value.